Ligand compounds, conjugates, and applications thereof
This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that comprise one or more ligand moieties for an asialoglycoprotein receptor (ASGPR). Exemplary chemical entities can further...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
29.02.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that comprise one or more ligand moieties for an asialoglycoprotein receptor (ASGPR). Exemplary chemical entities can further comprise an oligonucleotide. Said chemical entities are useful, e.g., in the targeted delivery of oligonucleotides to liver cells (e.g., liver parenchymal cells). The chemical entities are useful e.g., in the treatment of conditions or diseases caused by the expression (e.g., abnormal expression) of one or more genes in liver cells This disclosure also features compositions containing the same as well as methods of using and making the same. |
---|---|
AbstractList | This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that comprise one or more ligand moieties for an asialoglycoprotein receptor (ASGPR). Exemplary chemical entities can further comprise an oligonucleotide. Said chemical entities are useful, e.g., in the targeted delivery of oligonucleotides to liver cells (e.g., liver parenchymal cells). The chemical entities are useful e.g., in the treatment of conditions or diseases caused by the expression (e.g., abnormal expression) of one or more genes in liver cells This disclosure also features compositions containing the same as well as methods of using and making the same. |
Author | ZHAO, Haoting ZHANG, Bill Biliang |
Author_xml | – fullname: ZHAO, Haoting – fullname: ZHANG, Bill Biliang |
BookMark | eNrjYmDJy89L5WQw88lMT8xLUUjOzy3IL81LKdYBMvOyStMTS1KBbJBUYkFBTmZyYklmfl6xQklGalFqfhoPA2taYk5xKi-U5mZQcXMNcfbQTS3Ij08tLkhMTs1LLYl3DDUyMDI0MTI0NDN0cjIyJlIZALchMJY |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | AU2021421161BB2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU2021421161BB23 |
IEDL.DBID | EVB |
IngestDate | Fri Aug 02 08:55:54 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU2021421161BB23 |
Notes | Application Number: AU20210421161 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240229&DB=EPODOC&CC=AU&NR=2021421161B2 |
ParticipantIDs | epo_espacenet_AU2021421161BB2 |
PublicationCentury | 2000 |
PublicationDate | 20240229 |
PublicationDateYYYYMMDD | 2024-02-29 |
PublicationDate_xml | – month: 02 year: 2024 text: 20240229 day: 29 |
PublicationDecade | 2020 |
PublicationYear | 2024 |
RelatedCompanies | ARGORNA PHARMACEUTICALS CO., LTD |
RelatedCompanies_xml | – name: ARGORNA PHARMACEUTICALS CO., LTD |
Score | 3.523761 |
Snippet | This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
Title | Ligand compounds, conjugates, and applications thereof |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240229&DB=EPODOC&locale=&CC=AU&NR=2021421161B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dS8MwED_GFPVNp-LXpA-jTxbbru2ShyH2iyHuA9lkb6NpE5lIO2yH_76X0Gmf9O2SgyMJXO5-d7kLQK9vUzNDaGVkxE4QoFDXIBmjhjUwE4sLIdJExiHHE2-0cJ6W7rIFH7taGNUn9Es1R0SNSlHfK3Vfb36DWKF6W1neszVOFQ_xfBjqNTqWqQIE0KE_jGbTcBroQYBIUp-8SJ7lINjxLB8v7D3pSMtO-9GrL-tSNk2jEh_D_gzl5dUJtHjegcNg9_daBw7GdcobyVr7ylPwntdvCPw1-Qxc_oZU3iGZv29lJAxpyWrmozXp2_FCnEEvjubByMAFrH72u3pcNFbr2_1zaOdFzi9Ay9B_ICkbEMqJ02ckMV0cCVcwhxGX0kvo_inq6h_-NRzJQ1Ql2_QG2tXnlnfR6FbsVp3VN1ZVhL8 |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dS8MwED_GFOebTsWp0z6MPlls16_kYYhtV6pu3ZBO9jaafshE2mE7_Pe9lE77pG-XHBxJ4HL3u8tdAAbqkMoxQispJsMQAQrVJRIzKimmHCpJmqZRyOOQU9_wFtrTUl-24GNXC1P1Cf2qmiOiRkWo72V1X29-g1hO9bayuGNrnMrv3WDkiDU65qkCBNCONRrPZ87MFm0bkaTov3CeoiHYMRQLL-w9k_fn5c7Tq8XrUjZNo-Iewf4c5WXlMbSSrAsde_f3WhcOpnXKG8la-4oTMCbrNwT-An8Gzn9DKm6RzN63PBKGNGc189EC9-2SPD2FgTsObE_CBax-9rt6WDRWaw3VM2hneZacgxCj_0AiZhKaEE1lJJR1HKV6yjRGdEp70P9T1MU__BvoeMF0spo8-s-XcMgPtCrfplfQLj-3SR8NcMmuq3P7BrQAh6w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Ligand+compounds%2C+conjugates%2C+and+applications+thereof&rft.inventor=ZHAO%2C+Haoting&rft.inventor=ZHANG%2C+Bill+Biliang&rft.date=2024-02-29&rft.externalDBID=B2&rft.externalDocID=AU2021421161BB2 |